rhuFab V2

rhuFab V2 · Genentech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for rhuFab V2, covering 2013-06-21 to 2014-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration [Phase 3]

See pricing